Medivolve Inc.

Equities

MEDVF

CA58503M4083

Advanced Medical Equipment & Technology

Market Closed - OTC Markets Other stock markets 02:39:10 2024-04-26 pm EDT			5-day change	1st Jan Change
0.0082 ^USD	-28.70%		-36.92%	-24.77%

Apr. 02	Medivolve Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Jan. 16	Medivolve Inc. Announces Resignation of Peter Michel as Chief Financial Officer	CI

Medivolve Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022

May 16, 2022 at 07:14 pm EDT

Medivolve Inc. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CAD 16.69 million compared to CAD 11.25 million a year ago. Net loss was CAD 1.44 million compared to CAD 9.98 million a year ago.

Latest news about Medivolve Inc.

Medivolve Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 01	CI
Medivolve Inc. Announces Resignation of Peter Michel as Chief Financial Officer	Jan. 15	CI
Medivolve Inc. Announces Management Changes	Jan. 15	CI
Medivolve Inc. Announces the Resignation of Wen Ye as Board of Director	Nov. 16	CI
Medivolve Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
Medivolve Inc. Announces the Resignation of Beverley Richardson from its Board of Directors	Nov. 06	CI
Medivolve Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-13	CI
Medivolve Inc. Establishes Medivolve Management Services, LLC in Puerto Rico	23-05-15	CI
Medivolve Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-14	CI
Medivolve Inc.'s Equity Buyback announced on May 3, 2022, has expired.	23-05-02	CI
Medivolve Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-03	CI
Medivolve Inc. Auditor Raises 'Going Concern' Doubt	23-04-02	CI
Medivolve Inc. announced that it expects to receive CAD 4 million in funding	23-01-18	CI
Medivolve Inc. announced that it has received CAD 1.2 million in funding	23-01-10	CI
QuestCap Inc. cancelled the acquisition of a 40% stake in Spectral Analytics, Inc.	22-12-30	CI
Medivolve Inc. announced that it expects to receive CAD 1.2 million in funding	22-12-22	CI
Medivolve Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-13	CI
Medivolve Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-14	CI
Medivolve Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-16	CI
Medivolve Inc. (OTCPK:COPR.F) announces an Equity Buyback for 38,449,060 shares.	22-05-03	CI
Medivolve Inc. authorizes a Buyback Plan.	22-05-02	CI
Medivolve Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-30	CI
Medivolve Inc. Announces Chief Financial Officer Changes	22-02-28	CI
Medivolve Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-15	CI
Medivolve Inc. announced that it has received CAD 1.7 million in funding	21-11-08	CI

Chart Medivolve Inc.

Duration

Period

More charts

Company Profile

Medivolve, Inc. is a Canada-based healthcare technology company. The Company has two business units: Medivolve Pharmacy Division (MPD) and Collection Sites Diagnostics (CSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine, and psychiatry to patients in Southern California. CSDâs software platform, Electronic Health Records app (EHR), is focused on supporting clinical staff, is a series of assets and functionalities that enhance the customer experience and provide an end-to-end lab solution. The Company, through its subsidiaries, Medivolve Pharmacy Inc., and Kedy Ying Jao D.O., a medical corporation, operate a distributed network of two retail patient-care locations in California, United States. The Company has served hundreds of thousands of patients across the United States and facilitated more than 1,533,000 clinical tests.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-05-14 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Medical Software & Technology Services

	1st Jan change	Capi.
MEDIVOLVE INC.	-24.77%	222K
VEEVA SYSTEMS INC.	+4.36%	32.47B
PRO MEDICUS LIMITED	+16.51%	7.45B
SECTRA AB	+22.93%	3.89B
EVOLENT HEALTH, INC.	-16.29%	3.17B
OMNICELL, INC.	-25.96%	1.28B
LUNIT INC.	-36.14%	1.09B
B-SOFT CO.,LTD.	-35.42%	902M
SIMULATIONS PLUS, INC.	-0.13%	893M
VERADIGM INC.	-24.12%	857M

Medical Software & Technology Services